Mira Pharmaceuticals (MIRA) Non-Current Assets (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Non-Current Assets of $35439.0 for Q4 2025, little changed sequentially from $35439.0 in Q3 2025, and little changed YoY from $35439.0 in Q4 2024.
Mira Pharmaceuticals (MIRA) Non-Current Assets (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals has reported Non-Current Assets for 4 years, with the latest figure at $35439.0 in Q4 2025.
- Quarterly Non-Current Assets changed 0.0% year-over-year to $35439.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $141756.0 (down 40.9% YoY) and the FY2025 annual result came in at $35439.0, changed 0.0% from the prior year.
- Non-Current Assets held at $35439.0 in Q4 2025 per MIRA's latest filing, from $35439.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $3.4 million in Q2 2023 and troughed at $35439.0 in Q3 2024.
- A 4-year average of $645159.8 and a median of $35439.0 in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets sank 98.8% in 2024, then changed 0.0% in 2025.
- Over 4 years, Non-Current Assets stood at $363669.0 in 2022, then sank by 79.59% to $74213.0 in 2023, then slumped by 52.25% to $35439.0 in 2024, then changed by 0.0% to $35439.0 in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $35439.0, $35439.0, and $35439.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 59.27 Bn |
| 10 | Mira Pharmaceuticals | 18.47 Mn | 7.44 Mn | - | 35,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35,439.00 |
| Sep 30, 2025 | 35,439.00 |
| Jun 30, 2025 | 35,439.00 |
| Mar 31, 2025 | 35,439.00 |
| Dec 31, 2024 | 35,439.00 |
| Sep 30, 2024 | 35,439.00 |
| Mar 31, 2024 | 94,760.00 |
| Dec 31, 2023 | 74,213.00 |
| Sep 30, 2023 | 2.95 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Dec 31, 2022 | 363,669.00 |